CEL-SCI Corp (CVM)

0.3664 -0.03 (-7.92%) USD  |  NYAM  |  Jan 08, 16:00
0.3688 0.00 (0.00%) After-Hours: 20:00
More

CEL-SCI Research and Development Expense (Annual): 22.47M for Sept. 30, 2023

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for CVM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
AIM ImmunoTech Inc 10.94M
IGC Pharma Inc 3.773M
NovaBay Pharmaceuticals Inc 0.068M
Protalix BioTherapeutics Inc 17.09M
Palatin Technologies Inc 22.40M